Search
  • 网站搜寻
亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。
返回搜索结果

Dual-Enzyme Responsive Peptides


技术优势

Allows much greater selectivity and specificity Better-controlled degradation of opioid formulations


技术应用

Enzyme-responsive systems for diagnostic and drug delivery applications Selective biodegradation of materials for biomedical applications (i.e. location-specific degradation and drug release for abuse-deterrent opioid formulations)


详细技术说明

Researchers at UCLA have designed a dual-enzyme responsive peptide system that requires sequential digestion by two enzymes for cargo release from the C-terminus. In this system, the peptide is first cleaved by an enzyme that unmasks the recognition site for a second enzyme, allowing for digestion and release of the final product. These peptides can be used in polymeric formulations, either as cross-linkers or incorporated into the backbone, installing dual-enzyme sensitivity. This method may also be useful for delayed release formulations/prodrugs, allowing degradation of abuse-deterrent opioid formulations to be better controlled when sequences that require digestions by multiple enzymes are installed.


其他

State Of Development

Have demonstrated sequences that are responsive to trypsin/chymotrypsin, trypsin/papain, and trypsin/caspase 3.


Background

Due to their high selectivity and specificity, enzyme responsive systems are commonly used for diagnostic and drug delivery applications. Currently, most enzyme responsive technologies are sensitive to a single enzyme, or a single enzyme in combination with an environmental stimulus. For example, caspase-sensitive reporters, which respond to peroxide production or to cancer-related matrix metalloproteinases, have been designated to detect cell injury as well as to monitor reactivation of the apoptotic pathway after anti-cancer therapy delivery. Trypsin responsive sequences have been incorporated into abuse-deterrent opioid formulations, which allow drug release only at specific locations in vivo. Although many single-enzyme responsive systems show promise in specific targeting, response to more than one enzyme would allow for greater target selectivity and indirect enzyme detection, and provide information about cellular environments.


Additional Technologies by these Inventors


Tech ID/UC Case

29379/2017-446-0


Related Cases

2017-446-0


国家/地区

美国

欲了解更多信息,请点击 这里
Business of IP Asia Forum
桌面版